Glaucoma Drainage Devices Market Size, Share & Trends Analysis Report By Product (Conventional Glaucoma Drainage Devices, Minimally Invasive Glaucoma Surgery Devices), By End-User, By Region, And By Segment Forecasts, 2025-2034
Glaucoma Drainage Devices Market Size is valued at 808.4 Million in 2024 and is predicted to reach 2,130.5 Million by the year 2034 at an 10.3% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
- The primary drivers fueling the need for glaucoma drainage devices are the escalating prevalence of glaucoma as well as the growing incidence of lifestyle conditions such as diabetes and hypertension.
- The increasing prevalence of the elderly population, coupled with advancements in technology for product development, is propelling the growth of the Glaucoma Drainage Devices Market.
- North America dominated the market and accounted for a global revenue share in 2023.
- Regulatory hurdles delay the glaucoma drainage device market, affecting approval, market entry, and compliance with evolving regulations, potentially impeding growth and development.
Glaucoma drainage devices are used to drain and divert humor that is caused in the glaucoma condition which could lead to serious damage to the eye if not treated properly. Ill-treated glaucoma could also lead to blindness. The increasing prevalence of lifestyle disorders and the rising geriatric population are the prime factors driving the glaucoma drainage devices market potential over the forecast period. Increasing incidence of diabetes is also expected to further increase glaucoma and this will eventually favor the glaucoma drainage devices market potential over the coming years.
Technological innovations in glaucoma treatment and rising healthcare spending potential across the world are also expected to boost glaucoma drainage devices’ market growth across the forecast period. Hypertension is also responsible for the increasing incidence of glaucoma and could further propel the demand for glaucoma drainage devices through 2031.
The emergence of the COVID-19 pandemic in 2020 led to a downward trend in the global glaucoma drainage devices market owing to a heightened focus on coronavirus infections to control the pandemic situation. The glaucoma drainage devices market is anticipated to rise at a steady pace over the forecast period as the restrictions are lifted and the world returns to normal. However, complications related to glaucoma procedures are expected to have a hampering effect on the global glaucoma drainage devices demand through 2031.
Competitive Landscape
Some Major Key Players In The Glaucoma Drainage Devices Market:
- Alcon
- Henan Universe IOL R&M Co., Ltd.
- Alievio Inc
- Avisi Technologies LLC
- Geuder AG
- InnFocus Inc
- iVeena Delivery Systems Inc
- Merz Anteis SA
- MicroOptx, Inc.
- OPKO Health Inc
- Nova Eye Medical
- New World Medical, Inc.
- Santen SA
- Ivantis, Inc.
- Advanced Ophthalmic Innovations Pte Ltd
- iSTAR Medical
- Rheon Medical SA
- Johnson & Johnson Vision Care, Inc
- AbbVie Inc. (Allergan)
- Glaukos Corporation
- ASICO, LLC
- Lumenis Be Ltd.
- Carl Zeiss Meditec AG
- Katalyst Surgical
- Aurolab
- Novartis AG
- Corza Ophthalmology
- Ziemer Ophthalmic Systems
- Abbott Medical Optics
Market Segmentation:
The glaucoma drainage devices market is segmented on the basis of product and end-users. Based on the product, the market is segmented as valved implants and non-valved implants. By end-users, the market is segmented into hospitals, ophthalmic clinics, and other end-users.
Based On Product, The Valved Implants Segment To See High Demand
Valved implants are anticipated to see high demand over the forecast period and are anticipated to witness growth faster than the non-valved implants segment. Increasing preference for valved implants and rising recommendations for the same from healthcare professionals are expected to drive the growth of the segment over the forecast period.
Opthalmic Clinics To See High Demand
The hospitals segment is anticipated to account for a major market share over the forecast period owing to a rising number of glaucoma surgeries being performed. The presence of key glaucoma treatments and the availability of novel technologies are factors that could drive demand for glaucoma drainage devices in hospitals.
In The Region, The North America Glaucoma Drainage Devices Market Drives Global Growth.
The North America glaucoma drainage devices market is anticipated to emerge as the most lucrative one in the global glaucoma drainage devices industry landscape owing to the rising prevalence of glaucoma in the growing geriatric population. The increasing prevalence of diabetes is also a factor that propels glaucoma drainage devices demand in this region. Favorable reimbursement policies, developed healthcare infrastructure, high spending potential, and the presence of key healthcare providers are other factors that positively influence the glaucoma drainage devices market growth through 2031. The United States and Canada are projected to emerge as the most lucrative markets in the North America region over the years to come.
Glaucoma Drainage Devices Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 808.4 Million |
| Revenue Forecast In 2031 | USD 2,130.5 Million |
| Growth Rate CAGR | CAGR of 10.3% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape |
Alcon, Henan Universe IOL R&M Co., Ltd., Alievio Inc, Avisi Technologies LLC, Geuder AG, InnFocus Inc, iVeena Delivery Systems Inc, Merz Anteis SA, MicroOptx, Inc., OPKO Health Inc, Nova Eye Medical, New World Medical, Inc., Santen SA, Ivantis, Inc., Advanced Ophthalmic Innovations Pte Ltd, iSTAR Medical, Rheon Medical SA, and Johnson & Johnson Vision Care, Inc. AbbVie Inc. (Allergan), Glaukos Corporation, ASICO, LLC, Lumenis Be Ltd., Carl Zeiss Meditec AG,Katalyst Surgical, Aurolab, Novartis AG, Corza Ophthalmology, Abbott Medical Optics The Ziemer Ophthalmic System is among the other participants in the market. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Glaucoma drainage devices Market-
By Product-
- Conventional Glaucoma Drainage Devices
- Valveless
- Valved
- Minimally Invasive Glaucoma Surgery Devices
- Schlemm's Canal MIGS Devices
- Suprachoroidal MIGS Devices
- Subconjunctival MIGS Device
- Other Products
By End-Users-
- Hospitals
- Ophthalmic Clinics
- Other End-Users
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AbbVie Inc. (Allergan), Glaukos Corporation, ASICO, LLC, Lumenis Be Ltd., Carl Zeiss Meditec AG,Katalyst Surgical, Aurolab, Novartis AG, Corza Ophthal
Glaucoma Drainage Devices Market Size is valued at 808.4 Million in 2024 and is predicted to reach 2,130.5 Million by the year 2034
The Glaucoma Drainage Devices Market is expected to grow at an 10.3% CAGR during the forecast period for 2025-2034.
Glaucoma drainage devices market is segmented on the basis of product and end-users.
North America is leading the Glaucoma drainage devices market.